Tuesday, November 29, 2016 12:52:35 PM
This is a REAL company with REAL products. Nyloxin has made a huge difference in my life and I started using the Pet Pain-Away in my 13-year old dog with amazing results.
You keep saying "zero revenues" - that's not true. The revenues are low, but they exist. They did $300K in sales last year and about $70K last quarter. That may sound abysmal to you, but it's higher sales than over 100 other biotech companies that really have zero sales in the hope of a future product. Nutra Pharma is creating sales while they're working on their potential blockbuster drugs. They did receive Orphan Designation on their Multiple Sclerosis drug and they will be moving into trials shortly.
You can be as negative as you want, but this is an amazing opportunity at these prices and I'm buying as much as I can down here.
GLTYA
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM